Provectus Biopharmaceuticals, Inc. Stock OTC Bulletin Board
Equities
PVCT
US74373P1084
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
Financials (USD)
Sales 2022 | 0.99 | Sales 2023 | 0.56 | Capitalization | 40.27M |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -3M | EV / Sales 2022 | 48,121,944 x |
Net Debt 2022 | 2.16M | Net Debt 2023 | 2.95M | EV / Sales 2023 | 77,502,175 x |
P/E ratio 2022 |
-12.8
x | P/E ratio 2023 |
-13
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.58% |
Managers | Title | Age | Since |
---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 71 | 18-04-26 |
Eric A. Wachter
FOU | Founder | 61 | 01-12-31 |
Heather Raines
DFI | Director of Finance/CFO | 58 | 17-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric A. Wachter
FOU | Founder | 61 | 01-12-31 |
John W. Lacey
BRD | Director/Board Member | 76 | 18-04-26 |
President | 55 | 17-04-02 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PVCT Stock
- PVCT Stock